Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer

European Journal of Cancer

Volumn 46, Issue 11, 2010, Pages 2088-2096

  Hong, Angela ^a,b   Dobbins, Timothy ^c   Lee, C Soon ^a,d,e   Jones, Deanna ^a,b   Jackson, Elise ^a,b   Clark, Jonathan ^a   Armstrong, Bruce ^f   Harnett, Gerald ^g   Milross, Christopher ^a,b   O'Brien, Christopher ^a   Rose, Barbara ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

^e LIVERPOOL HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

^g PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Epidermal growth factor receptor; Human papillomavirus; Oropharyngeal cancer; p16; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P16; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CANCER; OVERALL SURVIVAL; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 77954213063     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.04.016     Document Type: Article

References (26)

1. J.A. Bonner, P.M. Harari, and J. Giralt Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck New Engl J Med 354 2006 567 578
2. G.R. Thomas, H. Nadiminti, and J. Regalado Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma Int J Exp Pathol 86 2005 347 363
3. T.C. Putti, K.F. To, and H.C. Hsu Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: A multicentre immunohistochemical study in the Asia-Pacific region Histopathology 41 2002 144 151
4. A.R. Chang, H.G. Wu, C.I. Park, Y.K. Jun, and C.W. Kim Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer Head Neck 30 2008 852 857
5. C.S. Kong, B. Narasimhan, and H. Cao The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas Int J Radiat Oncol Biol Phys 74 2009 553 561
6. C. Fischer, I. Zlobec, and E. Stockli Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas Human Pathol 39 2008 1527 1534
7. W. Li, C.H. Thompson, and C.J. O'Brien Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil Int J Cancer 106 4 2003 553 558
8. M.L. Gillison Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers J Clin Oncol 24 2006 5623 5625
9. P.M. Weinberger, Z. Yu, and B.G. Haffty Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 2006 736 747
10. C. Fakhry, W.H. Westra, and S. Li Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial J Natl Cancer Inst 100 2008 261 269
11. P. Lassen, J.G. Eriksen, and S. Hamilton-Dutoit Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 2009 1992 1998
12. M.L. Gillison, W.M. Koch, and R.B. Capone Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
13. R. Herrero, X. Castellsague, and M. Pawlita Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study J Natl Cancer Inst 95 2003 1772 1783
14. N. Reimers, H.U. Kasper, and S.J. Weissenborn Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 2007 1731 1738
15. B. Kumar, K.G. Cordell, and J.S. Lee EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer J Clin Oncol 26 2008 3128 3137
16. F. Perrone, S. Suardi, and E. Pastore Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma Clin Cancer Res 12 2006 6643 6651
17. L.H. Sobin, P. Hermanek, and R.V. Hutter TNM classification of malignant tumors. A comparison between the new (1987) and the old editions Cancer 61 1988 2310 2314
18. S.J. Smeets, A.T. Hesselink, and E.J. Speel A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen Int J Cancer 121 2007 2465 2472
19. K.K. Stanley, and E. Szewczuk Multiplexed tandem PCR: gene profiling from small amounts of RNA using SYBR Green detection Nucleic Acids Res 33 2005 e180
20. K.K. Ang, B.A. Berkey, and X. Tu Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356
21. S.M. Bentzen, B.M. Atasoy, and F.M. Daley Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial J Clin Oncol 23 2005 5560 5567
22. J. Bourhis, J. Overgaard, and H. Audry Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis Lancet 368 2006 843 854 (Pubitemid 44292807)
23. O.I. Olopade, T.A. Grushko, R. Nanda, and D. Huo Advances in breast cancer: pathways to personalized medicine Clin Cancer Res 14 2008 7988 7999
24. A. Johnston, and G. Salles Prognostic systems for lymphomas Hematol Oncol Clin North Am 22 2008 839 861 viii
25. A. Hong, A. Grulich, and D. Jones Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets Vaccine 28 2010 3269 3272
26. A. Nasman, P. Attner, and L. Hammarstedt Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125 2009 362 366